Myah. Age: 32.
Steady rates of recurrence in women with estrogen receptor-positive disease could influence decisions about long-term therapy. Even 20 years after a diagnosis, women with a type of breast cancer fueled by estrogen still face a substantial risk of cancer returning or spreading, according to a new analysis from an international team of investigators published in the New England Journal of Medicine. Standard treatment for estrogen receptor-positive, or ER-positive, breast cancer includes five years of the endocrine-based treatments tamoxifen or aromatase inhibitors, both of which are taken daily as a pill. The patients all received endocrine therapy for five years and were free of cancer when they stopped therapy.
Evangeline. Age: 32.
Breast Cancer Recurrence: Outlook / Prognosis
Our Sponsor:. While survival rates for breast cancer continue to improve, for some women, recurrence is a devastating reality. Our expert panel explores a topic filled with both challenge and hope.
Ava. Age: 20.
If your cancer comes back after treatment
Many women have no more problems after their original treatment for breast cancer. But sometimes breast cancer comes back. This can be a shock and you might need time to deal with the information your team gives you.
If you have been recently diagnosed, we will review your pathology to confirm you have received the correct diagnosis and staging information, and develop a personalized treatment plan. If you have a recurrence, we will perform comprehensive testing and identify a treatment approach tailored to your needs. Our cancer doctors use a variety of diagnostic tests to evaluate breast cancer and develop the appropriate treatment plan for you.